Inventor · disambiguated record
Richard C. Mulligan
Also filed as: MULLIGAN RICHARD · MULLIGAN RICHARD C
33 granted patents·20 pending applications·3,270 citations·filing 1986–2022
98Inventor score
Files withWHITEHEAD BIOMEDICAL INST12CHILDRENS MEDICAL CENTER10PASTEUR INSTITUT4SANA BIOTECHNOLOGY INC3BALAZS ALEJANDRO2
Top patents by PatentIndex Score
53 records- 0198US9458439B2Chromosomal modification involving the induction of double-stranded DNA cleavage and homologous recombination at the cleavage siteCHILDREN'S MEDICAL CENTER CORP·Filed 2014·Granted Oct 4, 2016·38 cites·43 claims
- 0298US4980286AIn vivo introduction and expression of foreign genetic material in epithelial cellsWHITEHEAD BIOMEDICAL INST·Filed 1989·Granted Dec 25, 1990·1.3k cites·16 claims
- 0398US4868116AIntroduction and expression of foreign genetic material in epithelial cellsWHITEHEAD BIOMEDICAL INST·Filed 1986·Granted Sep 19, 1989·567 cites·7 claims
- 0497US8921332B2Chromosomal modification involving the induction of double-stranded DNA cleavage and homologous recombination at the cleavage siteCHOULIKA ANDRé·Filed 2012·Granted Dec 30, 2014·164 cites·55 claims
- 0594US5904920ARegulation of systemic immune responses utilizing cytokines and antigensWHITEHEAD BIOMEDICAL INST·Filed 1995·Granted May 18, 1999·123 cites·9 claims
- 0693US7629326B2Chromosomal modification involving the induction of double-stranded DNA cleavage and homologous recombination at the cleavage sitePASTEUR INSTITUT·Filed 2006·Granted Dec 8, 2009·11 cites·4 claims
- 0792US5637483AIrradiated tumor cell vaccine engineered to express GM-CSFWHITEHEAD BIOMEDICAL INST·Filed 1994·Granted Jun 10, 1997·169 cites·17 claims
- 0891US7285538B2Gene repair involving in vivo excision of targeting DNAPASTEUR INSTITUT·Filed 2003·Granted Oct 23, 2007·30 cites·30 claims
- 0991US5891680ABioactive fusion proteins comprising the p35 and p40 subunits of IL-12WHITEHEAD BIOMEDICAL INST·Filed 1995·Granted Apr 6, 1999·141 cites·20 claims
- 1090US6254890B1Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acidsMASSACHUSETTS INST TECHNOLOGY·Filed 1998·Granted Jul 3, 2001·138 cites·41 claims
- 1189US5449614ARecombinant retroviruses with amphotropic and ecotropic host rangesWHITEHEAD INSTITUE FOR BIOMEDI·Filed 1994·Granted Sep 12, 1995·149 cites·28 claims
- 1287US5460959ATransduced fibroblastsWHITEHEAD BIOMEDICAL INST·Filed 1993·Granted Oct 24, 1995·103 cites·17 claims
- 1386US10259862B2VEGF-binding protein for blockade of angiogenesisCHILDRENS MEDICAL CENTER·Filed 2017·Granted Apr 16, 2019·6 cites·21 claims
- 1486US7960525B2Gene repair involving in vivo excision of targeting DNAPASTEUR INSTITUT·Filed 2007·Granted Jun 14, 2011·4 cites·9 claims
- 1585US5674722AGenetic modification of endothelial cellsSOMATIX THERAPY CORP·Filed 1994·Granted Oct 7, 1997·100 cites·54 claims
- 1682US5955331ARecombinant retroviruses with amphotropic and ecotropic host rangesWHITEHEAD BIOMEDICAL INST·Filed 1995·Granted Sep 21, 1999·47 cites·17 claims
- 1775US6140111ARetroviral gene therapy vectors and therapeutic methods based thereonWHITEHEAD BIOMEDICAL INST·Filed 1995·Granted Oct 31, 2000·44 cites·3 claims
- 1874US6958226B1Packaging cells comprising codon-optimized gagpol sequences and lacking lentiviral accessory proteinsCHILDRENS MEDICAL CENTER·Filed 1999·Granted Oct 25, 2005·32 cites·22 claims
- 1974US5521076AModified hepatocytes and uses thereforWHITEHEAD BIOMEDICAL INST·Filed 1991·Granted May 28, 1996·33 cites·5 claims
- 2073US2010111924A1Chromosomal Modification Involving the Induction of Double-Stranded DNA Cleavage and Homologous Recombination at the Cleavage SitePASTEUR INSTITUT·Filed 2009·Application pending·0 cites
- 2170US11999775B2VEGF-binding protein for blockade of angiogenesisCHILDRENS MEDICAL CENTER·Filed 2019·Granted Jun 4, 2024·0 cites·17 claims
- 2270US11517630B2Methods and compositions for regulating gene expressionCHILDRENS MEDICAL CENTER·Filed 2018·Granted Dec 6, 2022·0 cites·13 claims
- 2367US9701731B2VEGF-binding protein for blockade of angiogenesisCARTER BOB·Filed 2012·Granted Jul 11, 2017·2 cites·16 claims
- 2466US2017037434A1Chromosomal modification involving the induction of double-stranded dna cleavage and homologous recombination at the cleavage siteCHILDREN'S MEDICAL CENTER CORP·Filed 2016·Application pending·0 cites
- 2565US10159754B2Methods and compositions for regulating gene expressionCHILDRENS MEDICAL CENTER·Filed 2013·Granted Dec 25, 2018·0 cites·27 claims
- 2663US6060316AMethods of targeting of viral entryHARVARD COLLEGE·Filed 1999·Granted May 9, 2000·23 cites·28 claims
- 2763US2004019002A1Gene repair involving the induction of double-stranded DNA cleavage at a chromosomal target siteCHILDRENS MEDICAL CENTER·Filed 2003·Application pending·0 cites
- 2862US5580776AModified hepatocytes and uses thereforHUGHES HOWARD MED INST·Filed 1994·Granted Dec 3, 1996·19 cites·6 claims
- 2961US6544771B1Retroviral gene therapy vectors and therapeutic methods based thereonCELL GENESYS INC·Filed 1994·Granted Apr 8, 2003·20 cites·40 claims
- 3060US2024254168A1LIPID PARTICLES CONTAINING A TRUNCATED BABOON ENDOGENOUS RETROVIRUS (BaEV) ENVELOPE GLYCOPROTEIN AND RELATED METHODS AND USESSANA BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 3159US2009304641A1Methods and Compositions for Regulating Gene ExpressionCHILDRENS HOSPITAL BOSTON·Filed 2006·Application pending·0 cites
- 3259US2012165400A1Gene repair involving in vivo excision of targeting dnaCHOULIKA ANDRE·Filed 2011·Application pending·0 cites
- 3359US2002107214A1Gene repair involving the induction of double-stranded DNA cleavage at a chromosomal target siteCHILDREN S MEDICAL CT·Filed 2001·Application pending·0 cites
- 3459US2006014669A1Method for treating cancer and increasing hematocrit levelsUNIV LELAND STANFORD JUNIOR·Filed 2005·Application pending·0 cites
- 3556US2015056174A1Self-cleaving ribozymes and uses thereofMULLIGAN RICHARD·Filed 2012·Application pending·0 cites
- 3656US2005158741A1Self-cleaving ribozymes and uses thereofCHILDRENS HOSP MEDICAL CENTER·Filed 2004·Application pending·0 cites
- 3755US10233447B2Self-cleaving ribozymes and uses thereofTHE CHILDREN S MEDICAL CENTER CORP·Filed 2017·Granted Mar 19, 2019·0 cites·34 claims
- 3854US2004132675A1Method for treating cancer and increasing hematocrit levelsFiled 2002·Application pending·0 cites
- 3954US2023303665A1Modified anti-viral binding agentsSANA BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 4052US6316255B1Hepatocytes transduced with a retroviral vector comprising splice sitesWHITEHEAD BIOMEDICAL INST·Filed 1995·Granted Nov 13, 2001·6 cites·13 claims
- 4152US5698436AIntroduction and expression of foreign genetic material in epithelial cellsWHITEHEAD BIOMEDICAL INST·Filed 1995·Granted Dec 16, 1997·11 cites·12 claims
- 4252US2023190871A1Methods and compositions for treatment of viral infectionsSANA BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 4352US2002110898A1Gene repair involving in vivo excision of targeting DNACHILDRENS MEDICAL CENTER·Filed 2001·Application pending·0 cites
- 4452US2011061120A1Self-cleaving ribozymes and uses thereofCHILDRENS MEDICAL CENTER·Filed 2010·Application pending·0 cites
- 4550US8088585B2Methods for purifying hematopoietic stem cellsBALAZS ALEJANDRO·Filed 2004·Granted Jan 3, 2012·0 cites·10 claims
- 4648US2006084093A1Packaging cells comprising codon-optimized gagpol sequences and lacking lentiviral accessory proteinsLEE JENG-SHIN·Filed 2005·Application pending·0 cites
- 4746US8586100B2Populations of hematopoietic stem cellsBALAZS ALEJANDRO·Filed 2011·Granted Nov 19, 2013·0 cites·13 claims
- 4846US2010105136A1Chimeric t-cell receptors and t-cells targeting egfrviii on tumorsGEN HOSPITAL CORP·Filed 2007·Application pending·0 cites
- 4942US6001350AGenetic modification of endothelial cellsSOMATIX THERAPY CORP·Filed 1995·Granted Dec 14, 1999·20 cites·6 claims
- 5040US2002182192A1Methods for treating muscular dystrophyCHILDRENS MEDICAL CENTER·Filed 2002·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Richard C. Mulligan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →